IMPAACT at CROI 2021
The IMPAACT Network presented research in two oral presentations and six Science Spotlight™ presentations across six studies at CROI 2021.
Virtual meeting
Wednesday, 10 March
Protocol |
Title |
Authors |
Presentation Type |
|---|---|---|---|
| IMPAACT 2010 | Antepartum Weight Gain and Adverse Pregnancy Outcomes with Three Antiretroviral Regimens: IMPAACT 2010 | Hoffman RM, Ziemba L, Brummel S, Chinula L, Nematadzira T, Nakayiwa F, Stringer J, Krotje C, Jean-Philippe P, Coletti A, Zash R, Shapiro R, Sax P, Currier JS, Lockman S | Oral presentation, Maternal and Child HIV and SARS-CoV-2 Session, 11:15 AM - 1:15 PM ET |
| IMPAACT 2010 | Safety/Efficacy of DTG vs EFV, TDF vs TAF in Pregnancy/Postpartum: IMPAACT 2010 Trial | Chinula L, Brummel S, Ziemba L, McCarthy K, Johnston B, Chakhtoura N, Jean-Philippe P, Stranix-Chibanda L, Korutaro V, Cassim H, Lee F, Masheto G, Sax P, Currier JS, Lockman S | Oral presentation, Maternal and Child HIV and SARS-CoV-2 Session, 11:15 AM - 1:15 PM ET |
On Demand
Protocol |
Title |
Authors |
Presentation Type |
|---|---|---|---|
| P1026s | Optimizing Dolutegravir Initiation in Neonates using Population Pharmacokinetic Modeling | Piscitelli J, Nikanjam M, Momper J, Best B, Acosta E, Mirochnick M, Clarke DF, Capparelli E | Science Spotlight™ |
| PROMISE | Antiretroviral Therapy Adherence during & Post Breastfeeding Using TFV Levels in Hair | Nematadzira TG, Murnane PM, Baccheti R, Okochi H, Tallerico RM, Louie A, Chanaiwa VM, Vhembo T, Mutambanengwe M, Chipato T, Gandhi M, Stranix-Chibanda L, and the PROMISE Study Team | Science Spotlight™ |
| PROMISE 1077BF/1077FF | Preterm Birth, Breastfeeding, Antenatal ARV Regimen and 24-month HIV-free Survival | Fowler MG, Pinilla M, Dadabhai S, Owor M, Stranix-Chibanda L, Flynn P, Taha TE, Chinula L, Violari A, Moodley D, McCarthy K, Browning R, Brummel S, Mofenson L, for the PROMISE 1077BF/1077FF team | Science Spotlight™ |
| P1106/ PACTG 321 | Abacavir Dosing in Neonates from Birth: A Pharmacokinetic Analysis | Bekker A, Capparelli EV, Violari A, Cotton MF, Mathiba R, Wiznia A, Browning R, Moye J, Graham B, Decloedt E, Rabie H, Mirochnick M, Cressey TR, for the IMPAACT P1106 team | Science Spotlight™ |
| P1112 | Population Pharmacokinetics of VRC01LS in Term Infants and Adults | Yang J, Cunningham CK, McFarland EJ, Mascola JR, Graham BS, Ledgerwood J, Koup R, Coates E, Houser K, Gama L, Gaudinski MR, Muresan P, Perlowski C, Capparelli EV | Science Spotlight™ |
| IMPAACT 2014 | IMPAACT 2014 24-week PK and Safety of Doravirine/3TC/TDF in Adolescents with HIV-1 | Melvin AJ, Best B, Muresan P, Pasyar S, Teppler H, Yee K, McCarthy K, Scheckter R, Wan H, de Montigny L, Aurpibul L, Ounchanum P, Violari A, Tobin N and Townley E | Science Spotlight™ |